• $6,525.00
    Market Cap
  • 9,900.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
626,867
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
626,867
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
0
N/A
N/A
N/A
Depreciation and Amortization Expense
439,543
+3.47%
424,812
N/A
Total Operating Expenses
19.7M
+673.05%
2.5M
N/A
Operating Profit
-19.0M
+648.41%
-2.5M
N/A
Interest Income
504
-92.12%
6,400
N/A
Interest Expense
-428,249
-86.76%
-3.2M
N/A
Interest Income and Expense and Net
-427,745
-86.74%
-3.2M
N/A
Total Nonoperating Income and Expense
97,529
-99.42%
16.8M
N/A
Income before Taxes
-18.9M
+644.58%
-2.5M
N/A
Income Taxes
-36,356
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-18.9M
-232.66%
14.2M
N/A
Net Income from Continuing Operations Applicable to Common
-18.9M
-232.92%
14.2M
N/A
Basic EPS and Net Income
-0.45
-186.54%
0.52
N/A
Diluted EPS and Net Income
-0.45
-200.00%
0.45
N/A
Basic Weighted Average Shares
42.4M
+55.58%
27.3M
N/A
Diluted Weighted Average Shares
42.4M
+29.59%
32.7M
N/A
Balance Sheet
Cash and Cash Equivalents
193,198
+10,025.68%
1,908
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
193,198
+10,025.68%
1,908
N/A
Total Current Assets
472,221
+2,283.87%
19,809
N/A
Accumulated Depreciation
22,041
N/A
N/A
N/A
Property and Plant and Equipment and Net
97,403
N/A
N/A
N/A
Total Long-Term Assets
97,403
N/A
N/A
N/A
Total Assets
8.4M
+33.68%
6.3M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
5.0M
-41.08%
8.5M
N/A
Total Current Liabilities
9.9M
-32.95%
14.7M
N/A
Total Long-Term Debt
31,552
-59.55%
78,000
N/A
Total Long-Term Liabilities
206,763
+45.50%
142,102
N/A
Total Liabilities
10.1M
-38.07%
16.3M
N/A
Retained Earnings
-46.0M
+69.86%
-27.1M
N/A
Total Stockholders Equity
-1.7M
-83.40%
-10.0M
N/A
Total Shares Outstanding
56.0M
+103.06%
27.6M
N/A
Cash Flow
Cash from Operating Activities
-335,504
-1.54%
-340,749
N/A
Capital Expenditures
23,213
N/A
N/A
N/A
Cash from Investing Activities
9,937
+107.64%
-130,100
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
520,830
+11.05%
469,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
-3,036.93%
N/A
N/A
N/A
Return on Assets
-256.23%
-222.37%
209.39%
N/A
Return on Equity
324.53%
+504.56%
-80.22%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
0.05
+3,584.62%
0.001
N/A
Cash Ratio
0.02
+19,500.00%
0.0001
N/A
Debt-to-Equity Ratio
-3.05
+254.06%
-0.86
N/A
Debt-to-Assets Ratio
0.60
-56.05%
1.37
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow